๐ข ๐๐๐๐ ๐๐: Novo Nordisk Reports New Positive Data for Higher-Dose Wegovy Trial - $Novo Nordisk AS(NVO.US) $Hims & Hers Health(HIMS.US) $Eli Lilly(LLY.US)
๐ ๐๐๐ฒ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ:โค Novo reports new ๐๐๐๐ ๐๐ trial data for ๐๐๐ ๐จ๐ฏ๐ฒ ๐.๐ ๐ฆ๐ .โค Patients lost average ๐๐% body weight over ๐๐ weeks.โค Higher dose outperformed Wegovy ๐.๐ ๐ฆ๐ and placebo groups.โค Early responders on ๐.๐ ๐ฆ๐ lost nearly ๐๐% body weight.โค Study included ๐,๐๐๐+ adults with obesity without diabetes.โค ๐๐% of weight loss came from reduced ๐๐๐ญ ๐ฆ๐๐ฌ๐ฌ.โค Participants maintained ๐ฆ๐ฎ๐ฌ๐๐ฅ๐ ๐ฌ๐ญ๐ซ๐๐ง๐ ๐ญ๐ก despite significant weight reduction.The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments